| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 65.046 | 88.511 | 113.182 | 99.400 | 104.804 | 96.149 | 112.499 | 129.944 | 162.159 | 205.198 |
| Total Income - EUR | 65.046 | 88.511 | 113.182 | 99.400 | 105.236 | 101.178 | 110.040 | 130.357 | 163.392 | 206.424 |
| Total Expenses - EUR | 43.179 | 56.727 | 60.011 | 85.492 | 78.801 | 68.909 | 66.343 | 69.858 | 68.809 | 96.939 |
| Gross Profit/Loss - EUR | 21.867 | 31.784 | 53.171 | 13.909 | 26.435 | 32.269 | 43.697 | 60.499 | 94.583 | 109.485 |
| Net Profit/Loss - EUR | 19.916 | 29.128 | 48.726 | 12.914 | 25.382 | 31.330 | 42.728 | 59.226 | 93.157 | 104.068 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Escuhistomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 61.473 | 58.087 | 54.120 | 67.931 | 61.175 | 60.535 | 53.194 | 82.127 | 88.273 | 64.946 |
| Current Assets | 81.468 | 42.278 | 67.971 | 74.864 | 91.863 | 110.810 | 146.535 | 41.839 | 80.222 | 206.157 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 18.597 | 12.561 | 20.994 | 12.197 | 18.878 | 33.112 | 140.181 | 35.380 | 67.232 | 200.809 |
| Cash | 62.871 | 29.717 | 46.977 | 62.666 | 72.984 | 77.698 | 6.354 | 6.459 | 12.990 | 5.348 |
| Shareholders Funds | 81.207 | 44.004 | 52.562 | 64.512 | 88.645 | 118.294 | 158.399 | 59.274 | 93.205 | 196.752 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 61.734 | 56.361 | 69.484 | 78.239 | 64.350 | 53.009 | 41.289 | 58.878 | 70.728 | 71.081 |
| Income in Advance | 0 | 0 | 44 | 43 | 42 | 41 | 40 | 5.813 | 4.562 | 3.270 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Escuhistomed S.r.l.